These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 381862
1. The clofibrate trial--the lipid hypothesis retested. Med J Aust; 1979 Jun 02; 1(11):490-1. PubMed ID: 381862 [No Abstract] [Full Text] [Related]
2. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around. Fejfar Z. Cor Vasa; 1979 Jun 02; 21(6):377-9. PubMed ID: 397875 [No Abstract] [Full Text] [Related]
3. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. Br Heart J; 1978 Oct 02; 40(10):1069-118. PubMed ID: 361054 [No Abstract] [Full Text] [Related]
9. Hypolipaemic drugs and coronary heart disease. Howard AN. J Clin Pathol Suppl (R Coll Pathol); 1975 Dec 14; 9():106-14. PubMed ID: 783209 [No Abstract] [Full Text] [Related]
10. The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications. Rifkind BM. Monogr Atheroscler; 1985 Dec 14; 13():74-84. PubMed ID: 3911061 [No Abstract] [Full Text] [Related]
11. [Study of clofibrate. The opinion of Prof. D. Kritchevsky]. Fabbrocini V. Minerva Cardioangiol; 1980 Nov 14; 28(11):759-60. PubMed ID: 7231692 [No Abstract] [Full Text] [Related]
12. [Is hypolipemic treatment effective as a preventive measure?]. Rywik S. Przegl Lek; 1989 Nov 14; 46(7):619-23. PubMed ID: 2685917 [No Abstract] [Full Text] [Related]
13. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia]. Carlson LA, Olsson AG, Orö L, Rössner S. Lakartidningen; 1974 Sep 04; 71(36):3289-91. PubMed ID: 4605566 [No Abstract] [Full Text] [Related]
14. Clofibrate for prevention of myocardial infarction. Med Lett Drugs Ther; 1973 Apr 27; 15(9):37-8. PubMed ID: 4704699 [No Abstract] [Full Text] [Related]
15. Hypercholesterolemia: a reversible risk factor for coronary heart disease. Mishkel MA. CMAJ; 1989 Feb 15; 140(4):419. PubMed ID: 2644008 [No Abstract] [Full Text] [Related]
16. Association of low cholesterol with aggression. Peer DA, Stoukides CA. Ann Pharmacother; 1992 Jun 15; 26(6):785-6. PubMed ID: 1611162 [No Abstract] [Full Text] [Related]
17. [Effects on lipid metabolism of inhibitors of cholesterol synthesis]. Guarini G, Costa C, Trimarco C, Santese D, Vitaliano E. Clin Ter; 1988 Apr 15; 125(1):41-50. PubMed ID: 2974357 [No Abstract] [Full Text] [Related]
18. [Clofibrate--helpful or harmful?]. Hartmann G, Micheli H, Mordasini R, Noseda G, Stähelin HB. Schweiz Med Wochenschr; 1979 Aug 18; 109(31):1137-9. PubMed ID: 472701 [No Abstract] [Full Text] [Related]
19. [Trials of primary prevention by diet or hypolipidemic treatment]. Richard JL. Arch Mal Coeur Vaiss; 1992 Sep 18; 85 Spec No 2():97-103. PubMed ID: 1285703 [Abstract] [Full Text] [Related]
20. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators. Lancet; 1980 Aug 23; 2(8191):379-85. PubMed ID: 6105515 [Abstract] [Full Text] [Related] Page: [Next] [New Search]